• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Remifentanil Linked to Lower Postoperative Nausea and Vomiting After Thyroidectomy

by
November 18, 2026
in Health
Reading Time: 3 mins read
0
Remifentanil Linked to Lower Postoperative Nausea and Vomiting After Thyroidectomy

Remifentanil Linked to Lower Postoperative Nausea and Vomiting After Thyroidectomy

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Female patients undergoing elective thyroidectomy experienced a lower incidence of postoperative nausea and vomiting when anesthetized with remifentanil compared with sufentanil, according to findings from a prospective observational study. Under a clinical protocol that combined standardized triple antiemetic prophylaxis with an ultrasound-guided nerve block, the choice of intraoperative opioid demonstrated a significant association with patient recovery outcomes over the first 48 hours following surgery.

The authors investigated this question by evaluating whether the pharmacokinetic properties of remifentanil versus sufentanil correspond to differences in nausea and vomiting rates.

The study enrolled 400 female patients undergoing elective thyroidectomy procedures who were divided into two groups based on the intraoperative opioid administered during anesthesia: a remifentanil group and a sufentanil group. To standardize baseline emetic control across both study arms, all participants received identical triple antiemetic prophylaxis consisting of dexamethasone, ondansetron, and diphenhydramine.

The primary clinical outcome evaluated was the cumulative incidence of postoperative nausea and vomiting during the 48-hour period following surgery. The overall rate of postoperative nausea and vomiting was 12.2 percent in the remifentanil cohort compared with 33.3 percent in the sufentanil cohort. This difference between the two intraoperative opioid regimens was statistically significant, with a reported two-sided significance level of P < 0.01.

Secondary clinical outcomes assessed both the incidence and the severity of postoperative nausea and vomiting across distinct recovery phases, as well as postoperative pain levels. Patients receiving remifentanil had lower incidences and lower severity of nausea and vomiting during both the short-term window (defined as 5 to 30 minutes following conscious extubation) and the long-term window (ranging from 30 minutes to 48 hours post-extubation), with all comparisons reaching statistical significance (all P < 0.05). Assessments of postoperative pain scores measured at rest and during coughing or swallowing showed no statistically significant differences between the remifentanil and sufentanil groups at fixed postoperative evaluation points (all P > 0.05).

The investigators also examined whether a pre-existing history of motion sickness altered the observed relationship between opioid selection and postoperative emetic symptoms. An interaction test between opioid type and motion sickness history was not statistically significant (odds ratio 0.37, 95% confidence interval 0.13 to 1.11, P = 0.08). In an exploratory stratified analysis, remifentanil remained associated with a lower incidence of nausea and vomiting among patients with a history of motion sickness (odds ratio 0.19, 95% confidence interval 0.08 to 0.41, P < 0.01) as well as among patients without motion sickness history (odds ratio 0.43, 95% confidence interval 0.19 to 0.97, P = 0.04). The clinical study was registered with the Chinese Clinical Trial Registry under identifier ChiCTR2500107369.

Methodological specifications established that all statistical evaluations were conducted as two-sided tests, with significance defined at a threshold of P less than 0.05 across all primary and secondary endpoints.

In their conclusions, the investigators emphasized that the reduced incidence of postoperative nausea and vomiting associated with remifentanil occurred within a specific multi-component anesthetic framework that combined triple antiemetic prophylaxis with an ultrasound-guided bilateral superficial cervical plexus block. Because the research was conducted as a prospective observational study in female patients undergoing elective thyroidectomy, the findings establish an observed clinical association rather than a direct causal relationship.

Subject of Research: Association between intraoperative opioid selection and postoperative nausea and vomiting after thyroid surgery

Article Title: Association of intraoperative opioid type with postoperative nausea and vomiting in female patients undergoing thyroidectomy: a prospective observational study

Article References: Li, S., Liu, Y., Zhao, X., Li, X., Wang, Y., & Liu, H. (2026). Association of intraoperative opioid type with postoperative nausea and vomiting in female patients undergoing thyroidectomy: a prospective observational study. BMC Anesthesiology. https://doi.org/10.1186/s12871-026-04435-1

Image Credits: AI Generated

DOI: 10.1186/s12871-026-04435-1

Keywords: remifentanil, sufentanil, postoperative nausea and vomiting, thyroidectomy, female patients, intraoperative opioids, elective thyroidectomy, triple antiemetic prophylaxis, dexamethasone, ondansetron, diphenhydramine, superficial cervical plexus block, motion sickness history, conscious extubation, postoperative pain scores, prospective observational study

News Source: Ophelia Keating. (November 18, 2026). Remifentanil Linked to Lower Postoperative Nausea and Vomiting After Thyroidectomy. Scienmag.

Tags: conscious extubationdexamethasonediphenhydramineelective thyroidectomyfemale patientsintraoperative opioidsmotion sickness historyondansetronpostoperative nausea and vomitingpostoperative pain scoresprospective observational studyremifentanilsufentanilsuperficial cervical plexus blockthyroidectomytriple antiemetic prophylaxis
Share12Tweet7Share2ShareShareShare1

Related Posts

No Correlation Found Between Interprofessional Training and Students Readiness for Collaboration

No Correlation Found Between Interprofessional Training and Students Readiness for Collaboration

November 18, 2026
Global Childhood Cancer Rates Rise as Registries Reveal Stark Survival Disparities

Global Childhood Cancer Rates Rise as Registries Reveal Stark Survival Disparities

November 18, 2026

Lower Common Iliac Vein Confluence Narrows Anterior L5-S1 Surgical Window

November 18, 2026

Smartphone Model Accurately Estimates Blood Pressure Under Real-World Daily Living Conditions

November 18, 2026

POPULAR NEWS

  • Level Two Brain Tumor Surgery in Mexico Linked to Higher Mortality

    Level Two Brain Tumor Surgery in Mexico Linked to Higher Mortality

    29 shares
    Share 12 Tweet 7
  • New Decision Aid Supports Patients Selecting Obstructive Sleep Apnea Treatment

    29 shares
    Share 12 Tweet 7
  • Thermodynamic Models Reveal Contrasting Atomic Ordering in Liquid Thallium Alloys

    29 shares
    Share 12 Tweet 7
  • Higher Professional Self-Efficacy Linked to Reduced Missed Nursing Care

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

No Correlation Found Between Interprofessional Training and Students Readiness for Collaboration

Global Childhood Cancer Rates Rise as Registries Reveal Stark Survival Disparities

Lower Common Iliac Vein Confluence Narrows Anterior L5-S1 Surgical Window

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.